Home
TLRY

TLRY

Tilray Brands Inc.

as of 12-15-2025 10:28am EST

$11.68

$0.37

-3.06%

Stocks Health Care Medicinal Chemicals and Botanical Products Nasdaq

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mostly from alcohol.

Chart Type:

Time Range:

Founded:	N/A	Country:	Canada
Employees:	N/A	City:	NEW YORK
Market Cap:	1.7B	IPO Year:	2018
Target Price:	$150.00	AVG Volume (30 days):	9.5M
Analyst Decision:	Buy	Number of Analysts:	3
Dividend Yield:	N/A	Dividend Payout Frequency:	N/A
EPS:	-23.02	EPS Growth:	N/A
52 Week Low/High:	$3.51 - $23.20	Next Earning Date:	01-09-2026
Revenue:	$830,766,000	Revenue Growth:	2.31%
Revenue Growth (this year):	7.28%	Revenue Growth (next year):	4.51%

AI-Powered TLRY Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 16 hours ago

AI Recommendation

hold

Model Accuracy: 75.95%

75.95%

Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

View Full TLRY Forecast & Prediction with Hourly Data

Compare TLRY vs Leading Stocks

See how TLRY stacks up against similar companies in the market

Share on Social Networks:

Tools & Resources

Enhance your trading experience with our free tools

Free TLRY Stock Widget

Embed our interactive stock ticker widget on your website for real-time updates.

Free Tool

Stock Alerts on Telegram

Get instant notifications, market insights, and expert analysis delivered to your phone.

Live Updates

Disclaimer

The information presented on this page, "TLRY Tilray Brands Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.